Juan P. Frías
Juan P. Frías publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Metabolism, Diabetes, and Cancer.
- World rank
- #176,783 of 7,710,434 ranked researchers
- Rank in United States
- #66,056 of 1,627,098
- Works
- 312
- Citations
- 23k
- Citations per work
- 74.1
What does Juan P. Frías research?
Juan P. Frías's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences21268.0%
- Medicine21268.0%
- Everything else5818.7%
- Life Sciences4113.3%
- 1Endocrinology, Diabetes and Metabolism48% of their works
- 2Molecular Biology13% of their works
- 3Surgery10% of their works
- 4Epidemiology4% of their works
- 5Pharmacology4% of their works
- 6Cardiology and Cardiovascular Medicine2% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Bariatric Surgery and Outcomes
- Pancreatic function and diabetes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pharmacology and Obesity Treatment
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Juan P. Frías's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Cardiovascular Outcomes, Glucose Control, Diabetes, Cardiovascular Disease and Continuous Glucose Monitoring.
- Insulin Resistance
- Anti-Obesity Drugs
- Critical Care
- Pancreatic Islets
- Bariatric Surgery
- Weight Loss
- Metformin
- Obesity
- Continuous Glucose Monitoring
- Diabetes
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Type 2 Diabetes
- Glucose Control
- Cardiovascular Disease
- Hypoglycemia
- AMP-Activated Protein Kinase
- Diabetes Mellitus
- Lifestyle Intervention
- Metabolic Surgery
- ß-Cell Dysfunction
- Hyperglycemia
- Pharmacotherapy
- Metabolic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Glycemic Control3213 topics
- Insulin Therapy3213 topics
- Type 2 Diabetes2262 topics
- Cardiovascular Outcomes1921 topic
- Glucose Control1921 topic
- Diabetes1593 topics
- Cardiovascular Disease1252 topics
- Continuous Glucose Monitoring981 topic
- Hypoglycemia981 topic
- Obesity893 topics
- AMP-Activated Protein Kinase771 topic
- Metformin771 topic
- Diabetes Mellitus642 topics
- Weight Loss622 topics
- Lifestyle Intervention612 topics
- Bariatric Surgery341 topic
- Metabolic Surgery341 topic
- Pancreatic Islets331 topic
- ß-Cell Dysfunction331 topic
- Critical Care311 topic
- Hyperglycemia311 topic
- Anti-Obesity Drugs281 topic
- Pharmacotherapy281 topic
- Insulin Resistance271 topic
- Metabolic Syndrome271 topic
Where does Juan P. Frías work?
Juan P. Frías's main affiliation in the publication record is National Research Institute, United States.
How many publications and citations does Juan P. Frías have?
OpenAlex counts 312 works and 23,111 citations for Juan P. Frías, an h-index of 64, ranking #176,783 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Juan P. Frías. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.